Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
about
Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) LigandsNovel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.Allostery at opioid receptors: modulation with small molecule ligands.Placement of Hydroxy Moiety on Pendant of Peptidomimetic Scaffold Modulates Mu and Kappa Opioid Receptor Efficacy.In Vivo Effects of μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Peptidomimetics Following Acute and Repeated Administration.
P2860
Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Further Optimization and Evalu ...... ancing MOR and DOR Affinities.
@ast
Further Optimization and Evalu ...... ancing MOR and DOR Affinities.
@en
type
label
Further Optimization and Evalu ...... ancing MOR and DOR Affinities.
@ast
Further Optimization and Evalu ...... ancing MOR and DOR Affinities.
@en
prefLabel
Further Optimization and Evalu ...... ancing MOR and DOR Affinities.
@ast
Further Optimization and Evalu ...... ancing MOR and DOR Affinities.
@en
P2093
P2860
P1476
Further Optimization and Evalu ...... lancing MOR and DOR Affinities
@en
P2093
Emily M Jutkiewicz
Henry I Mosberg
Irina D Pogozheva
Jessica P Anand
John R Traynor
Nicholas W Griggs
P2860
P304
P356
10.1021/ACS.JMEDCHEM.5B01270
P407
P577
2015-11-13T00:00:00Z